Erythrocin Lactobionate (Hospira, Inc.)


Welcome to the PulseAid listing for the Erythrocin Lactobionate drug offered from Hospira, Inc.. This Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hospira, Inc.
NON-PROPRIETARY NAME: ERYTHROMYCIN LACTOBIONATE
SUBSTANCE NAME: ERYTHROMYCIN LACTOBIONATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2005-05-25
END MARKETING DATE: 0000-00-00


Erythrocin Lactobionate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionErythrocin Lactobionate from Hospira, Inc.
LABELER NAME: Hospira, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 500(mg/10mL)
START MARKETING DATE: 2005-05-25
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0409-6482_30b5f10e-c498-4ffd-86b8-f5228f892461
PRODUCT NDC: 0409-6482
APPLICATION NUMBER: NDA050609

Other ERYTHROMYCIN LACTOBIONATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Hospira, Inc.Erythrocin Lactobionate